Actualités HeartSciences Inc - HSCS | Actions NASDAQ

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences...

Statement of Beneficial Ownership (sc 13d)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of...

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

Southlake, Texas, May 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:...

HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG

Southlake, Texas, May 09, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:...

HeartSciences to Participate at the Inaugural EF Hutton Global Conference

Southlake, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference

Southlake, Texas, May 02, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq:...

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

Southlake, Texas, April 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Table of Contents Filed Pursuant to Rule 424(b)(3)Registration No. 333-270956 PROSPECTUS Up...

Current Report Filing (8-k)

false00014684920001468492us-gaap:WarrantMember2023-03-202023-03-2000014684922023-03-202023-03-200001468492us-gaap:CommonStockMember2023-03-202023...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3)Registration No. 333-265024 PROSPECTUS SUPPLEMENT NO. 14(TO PROSPECTUS DATED JUNE 17, 2022) 1,500,000...

Current Report Filing (8-k)

false00014684920001468492us-gaap:WarrantMember2023-03-162023-03-1600014684922023-03-162023-03-160001468492us-gaap:CommonStockMember2023-03-162023...

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

Southlake, Texas, March 16, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3)Registration No. 333-265024 PROSPECTUS SUPPLEMENT NO. 13(TO PROSPECTUS DATED JUNE 17, 2022) 1,500,000...

Amended Current Report Filing (8-k/a)

0001468492true0001468492us-gaap:WarrantMember2023-02-162023-02-1600014684922023-02-162023-02-160001468492us-gaap:CommonStockMember2023-02-162023...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3)Registration No. 333-265024 PROSPECTUS SUPPLEMENT NO. 12(TO PROSPECTUS DATED JUNE 17, 2022) 1,500,000...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

HeartSciences Inc (HSCS)

Votre Hub pour des idées et discussions en direct en temps réel

HSCS Actualités

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

Statement of Beneficial Ownership (sc 13d)

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG

HeartSciences to Participate at the Inaugural EF Hutton Global Conference

HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Amended Current Report Filing (8-k/a)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

HeartSciences Inc (HSCS) Actualités

HeartSciences Inc (HSCS)

Votre Hub pour des idées et discussions en direct en temps réel

HSCS Actualités

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

Statement of Beneficial Ownership (sc 13d)

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG

HeartSciences to Participate at the Inaugural EF Hutton Global Conference

HeartSciences to Participate in The Benchmark Company’s Virtual Individual Investor Healthcare Conference

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Amended Current Report Filing (8-k/a)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application